References
- 1. Michael MB, Erika OW, Robert JG. Diagnosis and Management of Endometrial Cancer. Fam Physician. 2016 Mar 15;93(6):468-74.
- 2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer Incidence and Mortality Worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015 Mar 1;136(5 ): E359-86. https://doi:10.100injc.29210
- 3. Andrew MG, James A.L.B, Michael JK. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastatic Rev. 2015; 34(1): 145155.- Published online 2015 Feb 27. https://doi:10.1007/s10555-015-9551-7
- 4. Romaszko-Wojtowicz A, Buciñski A, Doboszyñska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clinical and Experimental Medicine. 2018 Aug;18(3):391-397. https://doi:10.1007/s10238-018-0498-1.
- 5. Jenny N, Toshima ZP, Khalil H, Elisabeth KS, Zakaria E, Per K, Salmir N, and Aniko K. Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018. Breast Cancer Res Treat. 2020 Nov.; 184(1): 221228. https://doi:10.1007/s10549-020-05822-z
- 6. Mehmet SC, Suresh M. Multiple Primary Tumors over a lifetime. Oncology (Williston Park). 2019 Jul 16;33(7): 629384
- 7. Pariyada T, Bhoom S, Nurchavadee V, Panudeth J, Benjarat T, Cholticha V, Suwanit T, Somsri L, and Vitton C. Risks and cancer associations of metachronous and synchronous multiple primary cancers. BMC Cancer. 2021 Sep 23; 21(1): 1045. https://doi:10.1186/s12885-021-08766-9
- 8. Chang-Ching Y, Peng-Hui W, Chiung-Ru L, Min-Shyen Y, Kuan-Cjong CF. Synchronous breast invasive ductal carcinoma and endometrial endometrioid adenocarcinoma: A case report. J Obstet Gynaecol Res. 2011 Sep; 37(9):1246-9. https://doi.org/10.1111/j.1447-0756.2010.01502.x
- 9. Lv M, Zhang X, Shen Y, Wang F, Yang J, Chen Z, Li P, Zhang X, Li S, Yang J. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore). 2017 Apr;96 (17):e6799. https://doi:10.1097/MD.0000000000006799
- 10. Ali AT. Risk factors for endometrial cancer. Ceska Gynekologie. 2013 nov; 78(5):448-459
- 11. Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Prevention of Breast Cancer. International Journal of Biological Sciences. 2017; 13(11): 13871397. https://doi:10.7150/ijbs.21635
- 12. Adel E.B. MDCT evaluation of synchronous breast carcinoma and other solid malignancies. Breast Disease. 2021;40(4):275-281. https://doi:10.3233/BD-201065
- 13. Matthias M and Rosemarie F. MRI of endometrium cancer how we do it. Cancer Imaging. 2016 May 9;16:11. https://doi:10.1186/s40644-016-0069-1
- 14. Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee Si. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 Apr; 287(1): 176184. https://doi:10.1148/radiol.2017170963
- 15. Bruzonne M, Miglietta L, Franzone P, Gadducci A, Boccardo F. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients-Author links open overlay panel. Gynecologic Oncology. 2004 May; 93(2):345-52. https://doi.org/10.1016/j.ygyno.2004.02.008
- 16. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Prognostic factor and patterns of recurrence. Cancer. 1993 June 1;71(11):3697-702. https://doi:10.1002/1097-0142(19930601)71:11---lt---3697::aid-cncr2820711137---gt---3.0.co;2-u.
- 17. Georgescu MT, Georgescu DE, Georgescu TF, Serbanescu GL. Changing the prognosis of metastatic cervix uteri adenosquamous carcinoma through multimodal approach: a case report. Case reports in Oncology. 2020 Sep-Dec; 13(3): 1545-1551. https://doi:10.1159/000511564
- 18. Georgescu MT, Moldoveanu VG, Ileanu BV, Anghel R. Dosimetric influence of uterus position in cervix cancer high-dose-rate brachytherapy. Romanian Journal in Physics. 2016 Vol. 61, Nos. 910, P. 15571566.
- 19. Georgescu MT, Anghel R. Variation in uterus position prior to brachytherapy of cervix: A case report. Journal of Medicine and Life. 2017 Jan-Mar; 10(1): 9093.
- 20. Shu-Lian W, Hui F, Yong-Wen S, Wei-Hu W, Chen H, Yue- Ping L, Jing J, Xin-Fan L, Zi-hao Y, Hua R, Ning L, Ning-Ning L, Yu T, Yuan Y, Shu-Nan Q, Guang-yi S, Ran P, Shuai L, Bo C, Yong Y, Ye-Xiong L. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomized, non-inferiority, open-label. The Lancet Oncology. 2019 Mar;20(3):352-360. https://doi:10.1016/S1470-2045(18)30813-1
- 21. Schwartz GF, Cantor RI, Biermann WA. Neoadjuvant Chemotherapy Before Definitive Treatment for Stage III Carcinoma of the Breast. Archives of Surgery(Chicago, III:1960). 1987 Dec; 122(12):1430-1434. https://doi:10.1001/archsurg.1987.01400240078014